Information Provided By:
Fly News Breaks for March 26, 2018
EPIX
Mar 26, 2018 | 07:09 EDT
H.C. Wainwright analyst Joseph Pantginis started Essa Pharma with a Buy rating and 70c price target. The company is a "rebuild story with a significant rebound in its sights," Pantginis tells investors in a research note. He thinks the company is currently for longer term investors who are "willing to accept the volatility associated with the earlier stage news flow and time to first clinical readout being greater than 12 months away."
News For EPIX From the Last 2 Days
There are no results for your query EPIX